CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-28 | Gulino Richard L. SVP, General Counsel & Sec. | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2018-02-28 | Birznieks Gunther SVP, Business Development | Grant or award | +30,000 | 148,366 | ||
| 2018-02-28 | Birznieks Gunther SVP, Business Development | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2018-01-02 | Reverberi Gian Piero SVP & Chief Commercial Officer | Option exercise | +12,500 | 87,500 | ||
| 2018-01-02 | Reverberi Gian Piero SVP & Chief Commercial Officer | Option exercise | +7,500 | 110,000 | ||
| 2018-01-02 | Reverberi Gian Piero SVP & Chief Commercial Officer | Option exercise · Restricted Stock Unit | −12,500 | 25,000 | ||
| 2018-01-02 | Reverberi Gian Piero SVP & Chief Commercial Officer | Option exercise · Restricted Stock Unit | −7,500 | 15,000 |
Page 20 of 20 · 387 trades